Depomed, Amicus Therapeutics, and Portola Pharmaceuticals shares have been hit hard, but this Fool thinks they’re still captivating investment ideas.
Depomed, Amicus Therapeutics, and Portola Pharmaceuticals shares have been hit hard, but this Fool thinks they’re still captivating investment ideas.